Patient info Open main menu

Zinacef for injection or infusion – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Zinacef for injection or infusion

1 What Zinacef is and what it is used for

Zinacef is an antibiotic used in adults and

children. It works by killing bacteria that cause

infections. It belongs to a group of medicines

called cephalosporins.

Zinacef is used to treat infections of:

  • the lungs or chest
  • the urinary tract
  • the skin and soft tissue
  • the abdomen

Zinacef is also used:

  • to prevent infections during surgery.

Your doctor may test the type of bacteria causing

your infection and monitor whether the bacteria

are sensitive to Zinacef during your treatment.

2 What you need to know before you are

given Zinacef

You must not be given Zinacef :

  • if you are allergic to any

    cephalosporin antibiotics or any of the

    other ingredients of Zinacef (listed in section 6).

  • if you have ever had a severe allergic

    (hypersensitive) reaction to any other type of

    betalactam antibiotic (penicillins, monobactams

    and carbapenems).

  • if you have ever developed a severe skin rash

    or skin peeling, blistering and/or mouth sores

    after treatment with cefuroxime or any other

    cephalosporin antibiotics.

    Tell your doctor before you start on

    Zinacef if you think that this applies to you.

    You must not be given Zinacef.

Take special care with Zinacef

Serious skin reactions including Stevens-Johnson

syndrome, toxic epidermal necrolysis, drug

reaction with eosinophilia and systemic symptoms

(DRESS) have been reported in association with

cefuroxime treatment. Seek medical attention

immediately if you notice any of the symptoms

related to these serious skin reactions described

in section 4.

You must look out for certain symptoms such as

allergic reactions, skin rashes, gastrointestinal

disorders such as diarrhoea or fungal infections

while you are being given Zinacef. This will

reduce the risk of possible problems. See

(‘Conditions you need to look out for’) in section

  1. 4. If you have had any allergic reaction to other

antibiotics such as penicillin, you may also be

allergic to Zinacef.

If you need a blood or urine test

Zinacef can affect the results of urine or blood

tests for sugar and a blood test known as the

Coombs test. If you are having tests:

Tell the person taking the sample that you have been given Zinacef.

Other medicines and Zinacef

Tell your doctor if you are taking any other

medicines, if you’ve started taking any recently or

you start taking new ones. This includes medicines

you can obtain without a prescription.

Some medicines may affect how Zinacef works, or make it more likely that you’ll have side effects. These include:

  • aminoglycoside-type antibiotics
  • water tablets (diuretics), such as furosemide
  • probenecid
  • oral anticoagulants Tell your doctor if this applies to you. You may need extra check-ups to monitor your renal function while you are taking Zinacef.

Contraceptive pills

Zinacef may reduce the effectiveness of the contraceptive pill. If you are taking the contraceptive pill while you are being treated with Zinacef you also need to use a barrier method of contraception (such as a condom). Ask your doctor for advice.

Pregnancy and breast-feeding and fertility

Tell your doctor before you are given Zinacef:

  • if you are pregnant, think you might be

    pregnant or are planning to become pregnant

  • if you are breastfeeding

Your doctor will consider the benefit of treating you with Zinacef against the risk to your baby.

Driving and using machines

Don’t drive or use machines if you do not feel well.

Zinacef contains sodium

You need to take this into account if you are on a controlled sodium diet.

250 mg

This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free’.

750 mg

This medicine contains 42 mg sodium (main component of cooking/table salt) in each vial. This is equivalent to 2.1 % of the recommended maximum daily dietary intake of sodium for an adult.

1.5 g

This medicine contains 83 mg sodium (main component of cooking/table salt) in each vial. This is equivalent to 4.15 % of the recommended maximum daily dietary intake of sodium for an adult.

3 How Zinacef is given

Zinacef is usually given by a doctor or nurse. It can be given as a drip (intravenous infusion) or as an injection directly into a vein or into a muscle.

The usual dose

The correct dose of Zinacef for you will be decided by your doctor and depends on: the severity and type of infection, whether you are on any other antibiotics; your weight and age; how well your kidneys are working.

Newborn babies (0 - 3 weeks) For every 1 kg the baby weighs, they’ll be given 30 to 100 mg Zinacef per day divided in two or three doses.

Babies (over 3 weeks) and children For every 1 kg the baby or child weighs, they’ll be given 30 to 100 mg of Zinacef per day divided in three or four doses.

Adults and adolescents

750 mg to 1.5 g of Zinacef two, three or four times daily. Maximum dose: 6 g per day.

Patients with kidney problems

If you have a kidney problem, your doctor may change your dose.

Talk to your doctor if this applies to you.

4 Possible side effects

Like all medicines, Zinacef can cause side effects, although not everybody gets them. Conditions you need to look out for

A small number of people taking Zinacef get an allergic reaction or potentially serious skin reaction. Symptoms of these reactions include:

  • severe allergic reaction. Signs include

    raised and itchy rash, swelling,

    sometimes of the face or mouth causing difficulty in breathing.

  • skin rash, which may blister, and looks like

    small targets (central dark spot surrounded by a paler area, with a dark ring around the

    edge).

    • a widespread rash with blisters and

      peeling skin. (These may be signs of Stevens-Johnson syndrome or toxic epidermal necrolysis).

    • widespread rash, high body temperature and

      enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome).

    • chest pain in the context of allergic reactions,

      which may be a symptom of allergy triggered cardiac infarction (Kounis syndrome)

Other symptoms you need to be aware of while taking Zinacef include:

  • fungal infections on rare occasions,

    medicines like Zinacef can cause an overgrowth of yeast (Candida) in the body which can lead to fungal infections (such as thrush). This side effect is more likely if you take Zinacef for a long time.

  • severe diarrhoea

    (Pseudomembranous colitis). Medicines like Zinacef can cause inflammation of the colon (large intestine), causing severe diarrhoea, usually with blood and mucus, stomach pain, fever

    Contact a doctor or nurse immediately if you get any of these symptoms.

Common side effects

These may affect up to 1 in 10 people:

  • injection site pain, swelling and redness along

    a vein.

    Tell your doctor if any of these are troubling you.

Common side effects that may show up in blood tests:

  • increases in substances (enzymes) produced

    by the liver

  • changes in your white blood cell count

    (neutropenia or eosinophilia)

  • low levels of red blood cells (anaemia)

Uncommon side effects

These may affect up to 1 in 100 people:

  • skin rash, itchy, bumpy rash (hives)
  • diarrhoea, nausea, stomach pain

    Tell your doctor if you get any of these.

Uncommon side effects that may show up in blood tests:

  • low levels of white blood cells (leucopenia)
  • increase in bilirubin (a substance produced by

    the liver)

  • positive Coomb’s test.

Other side effects

Other side effects have occurred in a very small number of people but their exact frequency is unknown:

  • fungal infections
  • high temperature (fever)
  • allergic reactions
  • inflammation of the colon (large intestine),

    causing diarrhoea, usually with blood and mucus, stomach pain

  • inflammation in the kidney and blood vessels
  • red blood cells destroyed too quickly

    (haemolytic anaemia).

  • skin rash, which may blister, and looks like

    small targets (central dark spot surrounded by a paler area, with a dark ring around the edge) erythema multiformae.

    Tell your doctor if you get any of these.

Side effects that may show up in blood tests:

  • decrease in number of blood

    platelets (cells that help blood to

    clot - thrombocytopenia)

  • increase in levels of urea nitrogen and serum

    creatinine in the blood.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Zinacef

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date shown on the pack after EXP. The expiry date refers to the last day of that month.

Store below 25 °C. Keep the vial in the outer carton in order to protect from light.

When reconstituted for injection, can be stored for 5 hours if stored below 25 °C, or 72 hours if stored 2 to 8 °C.

When reconstituted for infusion, can be stored for 3 hours if stored below 25 °C, or 72 hours if stored 2 to 8 °C.

From a microbiological point of view, the medicine should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 °C unless reconstitution has taken place in controlled and validated aseptic conditions.

Do not throw away any medicines via wastewater or household waste. Your doctor or nurse will dispose of any medicine that is no longer required. These measures will help to protect the environment.

6 Contents of the pack and other

information

What Zinacef contains

250 mg powder for Injection or Infusion The active substance is cefuroxime. Each vial contains 250 mg of cefuroxime (as cefuroxime sodium).

750 mg powder for Injection or Infusion The active substance is cefuroxime. Each vial contains 750 mg of cefuroxime (as cefuroxime sodium).

1.5 g powder for Injection or Infusion

The active substance is cefuroxime. Each vial contains 1.5 g of cefuroxime (as cefuroxime sodium).

There are no other ingredients

What Zinacef looks like and contents of the pack

Colourless glass vials, with a bromobutyl rubber plug and aluminium overseal with flip off plastic lid, containing 250 mg, 750 mg or 1.5 g of cefuroxime (as cefuroxime sodium) powder.

The vials of cefuroxime powder may also be supplied with ampoules of water for injection as solvent

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder: Sandoz Pharmaceuticals d.d., Verovškova ulica 57, 1000 Ljubljana, Slovenia

Manufacturer: ACS Dobfar S.p.A., Via Alessandro Fleming 2, 37135 Verona, Italy

This leaflet was last revised in July 2024.

Trade marks are owned by or licenced to the Sandoz group of companies.

© 2021 Sandoz group of companies or its licensor.

.

. .

.

. .

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 48870/0040

Last revision stated in the text: July 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Zinacef for injection or infusion

Active substance Cefuroxime
Drug group (ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC02 cefuroxime
Marketing authorisation PL 48870/0040

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.